Skip to main content

Table 1 Demographics and baseline characteristics of the participants in the first oocyte retrieval cycle

From: Cumulative live birth rates for low-prognosis women over 5 years or 9 frozen-thawed embryo transfer cycles

Group

POSEIDON group

Control group

P value

Group1

Group2

Group3

Group4

Group5

Younger unexpected poor responders

Older unexpected poor responders

Younger expected poor responders

Older expected poor responders

Patients (n)

4470

2270

1110

1095

8753

 

Age of female

30.21 ± 2.76a

38.01 ± 2.83b

30.32 ± 2.71a,d

39.37 ± 3.38c

30.44 ± 3.85d

<0.05

Percentage of age

a

b

c

d

e

<0.05

  ≤ 30

2234 (50.0%)

0 (0.0%)

541 (48.7%)

0 (0.0%)

4760 (54.4%)

 

  > 30, ≤35

2236 (50.0%)

494 (21.8%)

569 (51.3%)

141 (12.9%)

3103 (35.5%)

 

  > 35, ≤40

0 (0.0%)

1360 (59.9%)

0 (0.0%)

564 (51.5%)

796 (9.1%)

 

  > 40

0 (0.0%)

416 (18.3%)

0 (0.0%)

390 (35.6%)

94 (1.1%)

 

AFC

11.17 ± 5.77a

8.99 ± 4.09b

2.19 ± 1.65c

2.51 ± 1.32c

15.24 ± 6.21d

<0.05

Percentage of AFC

a

b

c

c

d

<0.05

  < 4

0 (0.0%)

0 (0.0%)

750 (67.6%)

776 (70.9%)

0 (0.0%)

 

  ≥ 4, < 10

2185 (48.9%)

1502 (66.2%)

360 (32.4%)

319 (29.1%)

1444 (16.5%)

 

  ≥ 10

2285 (51.1%)

768 (33.8%)

0 (0.0%)

0 (0.0%)

7309 (83.5%)

 

Oocytes retrieved in the first cycle (n)

5.97 ± 2.31a

5.27 ± 2.34b

7.07 ± 6.67c

3.29 ± 3.05d

16.84 ± 6.57e

<0.05

Type of infertility

a

b

c

d

e

<0.05

 Primary

2673 (59.8%)

848 (37.4%)

713 (64.2%)

383 (35.0%)

5059 (57.8%)

 

 Secondary

1797 (40.2%)

1422 (62.6%)

397 (35.8%)

712 (65.0%)

3694 (42.2%)

 

Main etiology

a

b

c

d

e

<0.05

 Female

460 (10.3%)

240 (10.6%)

94 (8.5%)

69 (6.3%)

1076 (12.3%)

 

 Male

2945 (65.9%)

1401 (61.7%)

770 (69.4%)

741 (67.7%)

5567 (63.6%)

 

 Combined

539 (12.0%)

236 (10.4%)

126 (11.3%)

132 (12.0%)

1059 (12.1%)

 

 Others

526 (11.8%)

393 (17.3%)

120 (10.8%)

153 (14.0%)

1051 (12.0%)

 

Duration of infertility (years)

2.93 ± 2.42a

4.08 ± 3.96b

3.14 ± 2.46c

4.32 ± 4.56d

3.01 ± 2.70a,c

<0.05

Female BMI (kg/m2)

22.00 ± 4.74a

22.26 ± 3.07b

21.78 ± 5.87a,c

22.16 ± 2.88a,b

21.64 ± 3.31c

<0.05

Year of treatment

a

b

c

d

e

<0.05

 2013–2014

1160 (26.0%)

526 (23.2%)

309 (27.8%)

304 (27.8%)

2248 (25.7%)

 

 2015

859 (19.2%)

375 (16.5%)

258 (23.2%)

180 (16.4%)

1821 (20.8%)

 

 2016

1349 (30.2%)

730 (32.2%)

362 (32.6%)

348 (31.8%)

2188 (25.0%)

 

 2017

683 (15.3%)

353 (15.6%)

111 (10.0%)

172 (15.7%)

1353 (15.5%)

 

 2018

419 (9.4%)

286 (12.6%)

70 (6.3%)

91 (8.3%)

1143 (13.1%)

 

Gravidity

0.71 ± 1.27a

1.42 ± 1.53b

0.62 ± 1.04c

1.48 ± 1.52b

0.74 ± 1.09a

<0.05

Parity

0.06 ± 0.26a

0.27 ± 0.48b

0.05 ± 0.23a

0.30 ± 0.51b

0.08 ± 0.30c

<0.05

  1. Values are presented as mean ± SD or number (percentage). The differences were considered statistically significant when the p-value was less than 0.05. Different alphabets represent significant differences between groups. AFC Antral follicle count, BMI Body mass index
  2. a,b,c,d,e P<0.05